Specificity of piracetam's anti-amnesic activity in three models of amnesia in the mouse
- PMID: 3362958
- DOI: 10.1016/0091-3057(88)90030-5
Specificity of piracetam's anti-amnesic activity in three models of amnesia in the mouse
Abstract
The effects of piracetam on the amnesias induced by scopolamine, diazepam and electroconvulsive shock (ECS) were studied in a passive avoidance procedure in the mouse and compared with the interactions of piracetam with the major behavioral effects of these treatments, namely scopolamine-induced hyperactivity, diazepam-induced release of punished behavior (Four Plates Test) and ECS-induced convulsions. Amnesia was induced by injecting scopolamine or diazepam (1 mg/kg, IP) 30 minutes before or applying ECS immediately after the first session (S1) of the passive avoidance task. Piracetam was studied at 3 doses (512, 1024 and 2048 mg/kg) administered PO 60 minutes before S1. Retention was measured 24 hours later (S2) in the absence of any treatment. Piracetam dose-dependently attenuated the memory deficits induced by the three amnesic treatments but did not affect either scopolamine-induced hyperactivity, diazepam-induced release of punished behavior or ECS-induced convulsions. These results point to the specificity of piracetam's anti-amnesic activity and, in particular, suggest that piracetam can suppress the memory disturbances induced by diazepam without affecting diazepam's anxiolytic activity. The test battery employed would therefore seem highly suitable for evaluating the potential nootropic activity of novel compounds.
Similar articles
-
Reversal of scopolamine-induced amnesia and alterations in energy metabolism by the nootropic piracetam: implications regarding identification of brain structures involved in consolidation of memory traces.Brain Res. 1987 Oct 20;424(1):1-9. doi: 10.1016/0006-8993(87)91186-3. Brain Res. 1987. PMID: 3690290
-
Effect of piracetam and of standardized ginseng extract on the electroconvulsive shock-induced memory disturbances in "step-down" passive avoidance.Acta Physiol Pharmacol Bulg. 1987;13(2):11-7. Acta Physiol Pharmacol Bulg. 1987. PMID: 3673597
-
Brain neurotransmitter receptor binding and nootropic studies on Indian Hypericum perforatum Linn.Phytother Res. 2002 May;16(3):210-6. doi: 10.1002/ptr.1101. Phytother Res. 2002. PMID: 12164263
-
Pre-clinical evaluation of cognition enhancing drugs.Prog Neuropsychopharmacol Biol Psychiatry. 1989;13 Suppl:S99-115. doi: 10.1016/0278-5846(89)90114-0. Prog Neuropsychopharmacol Biol Psychiatry. 1989. PMID: 2694232 Review.
-
Herbal treatments for ECS-induced memory deficits: a review of research and a discussion on animal models.J ECT. 2000 Jun;16(2):144-56. doi: 10.1097/00124509-200006000-00006. J ECT. 2000. PMID: 10868324 Review.
Cited by
-
Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders.Drugs Aging. 1991 Jan;1(1):17-35. doi: 10.2165/00002512-199101010-00004. Drugs Aging. 1991. PMID: 1794001 Review.
-
Loss of function of NCOR1 and NCOR2 impairs memory through a novel GABAergic hypothalamus-CA3 projection.Nat Neurosci. 2019 Feb;22(2):205-217. doi: 10.1038/s41593-018-0311-1. Epub 2019 Jan 21. Nat Neurosci. 2019. PMID: 30664766 Free PMC article.
-
Cognition Enhancing Activity of Sulforaphane Against Scopolamine Induced Cognitive Impairment in Zebra Fish (Danio rerio).Neurochem Res. 2016 Oct;41(10):2538-2548. doi: 10.1007/s11064-016-1965-2. Epub 2016 Jun 2. Neurochem Res. 2016. PMID: 27255600
-
Efficacy study of Prunus amygdalus (almond) nuts in scopolamine-induced amnesia in rats.Indian J Pharmacol. 2010 Jun;42(3):168-73. doi: 10.4103/0253-7613.66841. Indian J Pharmacol. 2010. PMID: 20871769 Free PMC article.
-
Protective effect of rutin on cognitive impairment caused by phenytoin.Indian J Pharmacol. 2015 Nov-Dec;47(6):627-31. doi: 10.4103/0253-7613.169581. Indian J Pharmacol. 2015. PMID: 26729954 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources